News | Intravascular Imaging | September 11, 2015

Infraredx Acquired by Nipro Corp.

Japanese medical company Nipro wants to expand into intravascular imaging solutions, expand vascular portfolio to the United States

Infraredx, NIRS, IVUS

September, 11, 2015 – Japanese medical vendor Nipro Corp. signed a definitive agreement to acquire Infraredx Inc., maker of a combined intravascular ultrasound (IVUS) integrated with near infrared spectroscopy (NIRS) for the detection of lipid-core plaque (LCP) coronary plaque. 

Nipro offers medical products and technologies in a wide range of fields, including artificial organs, circulatory devices, test/diagnostic agents, injection/infusion solutions, pharmaceuticals and medical glass products. The agreement combines Nipro's strong global cardiovascular portfolio and resources along with Infraredx’s industry expertise in NIRS and intravascular ultrasound. The agreement will help introduce Nipro’s cardiovascular product line into the United States. 

The company plans to continue Infraredx’s strategic plans to continue clinical testing of NIRS as an advanced imaging tool required to predict heart attacks and shift from reactive treatment to proactive care of coronary artery disease.

“By teaming up with one of the leading global medical equipment manufacturing companies in the world, Infraredx is able to leverage Nipro’s global network and vast resources to enhance its presence and impact a larger audience locally as well globally,” said Jason Bottiglieri, president and CEO of Infraredx. “We are pleased to combine our strengths to meet the demands of the marketplace and continue to deliver to the medical community cardiovascular imaging systems that hold the potential to revolutionize the management of cardiovascular disease.”

The acquisition, which is subject to certain conditions, is expected to close in October 2015.

For more information: www.infraredx.com


Related Content

News | Intravascular Imaging

March 31, 2025 — Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is ...

Home April 02, 2025
Home
News | Intravascular Imaging

March 5, 2023 — Patients with complex coronary artery disease who underwent a stenting procedure guided by intravascular ...

Home March 05, 2023
Home
News | Intravascular Imaging

June 2, 2022 — With over 30 years' experience in vascular assessment, Huntleigh, a member of the Arjo family, has ...

Home June 02, 2022
Home
News | Intravascular Imaging
February 25, 2022 – Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis called ...
Home February 25, 2022
Home
News | Intravascular Imaging

December 15, 2021 — Conavi Medical Inc. has entered into agreements for over $20 million in funding to support ...

Home December 15, 2021
Home
News | Intravascular Imaging

October 18, 2020 – New data from the PROSPECT II study shows that near-infrared spectroscopy (NIRS) intravascular ...

Home October 18, 2020
Home
Technology | Intravascular Imaging

May 20, 2019 — Philips announced the launch of the new IntraSight interventional applications platform. The secure ...

Home May 20, 2019
Home
Videos | Intravascular Imaging

Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and advanced ...

Home September 26, 2018
Home
News | Intravascular Imaging

September 25, 2018 – New data demonstrate the correlation between the presence of non-flow-limiting, non-intervened-upon ...

Home September 25, 2018
Home
News | Intravascular Imaging

August 10, 2018 — Infraredx Inc. announced the Makoto Intravascular Imaging System, and accompanying Dualpro ...

Home August 10, 2018
Home
Subscribe Now